MD Anderson and Summit Therapeutics partner to accelerate ivonescimab development
The University of Texas MD Anderson Cancer Center and Summit Therapeutics, Inc. today announced a strategic five-year collaboration agreement for ...
Tag: Bispecific antibody
New method enhances the efficacy of bispecific antibody therapies in treating solid tumors
Professor Seung-Woo Lee and PhD candidate Kun-Joo Lee from the Department of Life Sciences at Pohang University of Science and ...
MD Anderson and Jazz Pharmaceuticals collaborate to investigate the potential of zanidatamab in HER2-expressing cancers
The University of Texas MD Anderson Cancer Center and Jazz Pharmaceuticals plc today announced a five-year strategic research collaboration agreement ...
MHRA grants conditional marketing authorization for AbbVie's Tepkinly to treat aggressive blood cancer
AbbVie today announced that the UK Medicines and Healthcare products Regulatory Agency has granted conditional Marketing Authorisation for Tepkinly® (epcoritamab) ...
Bispecific antibody exhibits high breadth and potency against SARS-CoV-2 Omicron sub-lineages
In a recent study posted to the bioRxiv* preprint server, researchers developed bispecific-antibodies (bsAbs) against severe acute respiratory syndrome coronavirus ...
